Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

CTI BioPharma Corp (CTIC) Stock Forecast 2025 - AI Price Prediction & Analysis

CTI BioPharma Corp (CTIC) AI Stock Price Forecast & Investment Analysis

CTI BioPharma Corp Stock Price Chart and Technical Analysis

Loading CTI BioPharma Corp interactive price chart and technical analysis...

CTI BioPharma Corp (CTIC) - Comprehensive Stock Analysis & Investment Research

Deep dive into CTI BioPharma Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CTI BioPharma Corp, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CTI BioPharma Corp: CTI BioPharma Corp operates in the Manufacturing sector, making it an emerging small-cap investment.

CTI BioPharma Corp (Stock Symbol: CTIC) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 128 professionals worldwide and operates under the strategic leadership of CEO Adam Craig.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CTI BioPharma Corp's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CTI BioPharma Corp: With $10M in annual revenue and -632.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $10 million generating a -632.8% net profit margin .

Market Capitalization: $1199 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -447.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CTI BioPharma Corp stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For CTI BioPharma Corp: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CTI BioPharma Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CTI BioPharma Corp's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CTI BioPharma Corp: Market positioning analysis based on available financial and operational metrics.

CTI BioPharma Corp strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 96.7% gross margin, indicating strong pricing power and operational efficiency.

CTI BioPharma Corp (CTIC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CTI BioPharma Corp stock analysis.

Loading CTI BioPharma Corp comprehensive fundamental analysis and insider trading data...

Deep dive into CTI BioPharma Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CTI BioPharma Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CTI BioPharma Corp: With a P/E ratio of -13.31, the market sees the stock as potentially undervalued.

P/E Ratio -13.31x
P/B Ratio -47.30x
Market Cap $1199M
EPS $-0.54
Book Value/Share $-0.19
Revenue/Share $0.57
FCF/Share $-0.64
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CTI BioPharma Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CTI BioPharma Corp: An ROE of -447.1% indicates room for improvement in shareholder value creation.

ROE -447.1%
ROA -135.3%
ROIC -191.7%
Gross Margin 96.7%
Operating Margin -514.7%
Net Margin -632.8%
EBT Margin -111.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CTI BioPharma Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CTI BioPharma Corp: A current ratio of 1.04 shows adequate liquidity.

Current Ratio 1.04x
Quick Ratio 1.00x
D/E Ratio 0.54x
Financial Leverage 19.23x
Interest Coverage -26.2x
Working Capital $37M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CTI BioPharma Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CTI BioPharma Corp: Free cash flow of $-98M indicates cash challenges that need attention.

Operating Cash Flow $-98M
Free Cash Flow $-98M
FCF/Sales -831.8%
CapEx/Sales 0.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CTI BioPharma Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CTI BioPharma Corp: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Receivables Turnover 0.9x
Inventory Turnover 0.4x
Fixed Assets Turnover 0.9x
Days Sales Outstanding 386 days
Days Inventory 1040 days
Payables Period 1471 days
Cash Conversion Cycle -3878 days
Understanding Financial Statement Data

What these metrics mean: Key figures from CTI BioPharma Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CTI BioPharma Corp: With annual revenue of $10M, CTI BioPharma Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $10M
Operating Income $-53M
Net Income $-66M
R&D Expense $5M
SG&A Expense $573M
Cost of Goods Sold $0M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 79%
Cash & Short-term Investments 74%
Total Liabilities 121%
Short-term Debt 36%
Accounts Receivable 2%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 132M
Growth Metrics (YoY)
EPS Growth -5.9%

Latest CTI BioPharma Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CTI BioPharma Corp (CTIC) stock price and investment outlook.

, source: Seeking Alpha

STOCKHOLM, June 26, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (CTIC) (CTI) announced today the completion of the acquisition of CTI by Sobi ...

, source: Nasdaq

This press release may contain forward-looking statements by Sobi that involve risks and uncertainties and reflect Sobi's judgment as of the date of this press release. These forward-looking ...

CTI BioPharma Corp Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of CTI BioPharma Corp against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - CTI BioPharma Corp Stock Forecast

How accurate are CTI BioPharma Corp stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for CTIC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence CTI BioPharma Corp stock price forecasts?

Our analysis considers CTI BioPharma Corp's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CTI BioPharma Corp a good investment in 2025?

Based on our AI analysis, CTI BioPharma Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CTI BioPharma Corp forecasts updated?

CTI BioPharma Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CTI BioPharma Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CTI BioPharma Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...